Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8077
Reference
MSAN(2024)06
Name
Lisdexamfetamine (Elvanse®) capsules
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
There will be intermittent supply of all strengths of lisdexamfetamine (Elvanse®) capsules until April 2024.
Supplies of various strengths of Elvanse® will be available at different times throughout this period.
ADHD service providers should continue to defer initiating patients on Elvanse capsules as initiating new patients will prolong the current supply disruptions.
Generic dexamfetamine 5mg tablets and Amfexa® (dexamfetamine) 5mg, 10mg, and 20mg tablets remain available but are unable meet large increases in demand.
Unlicensed supplies of lisdexamfetamine capsules can be sourced, lead times vary.
Supply disruptions affecting atomoxetine and guanfacine presentations have been resolved.
Contact Name
Contact Email
Contact Address
Pharmacy Team
Created
2024-03-06 11:50:00
Click to go back to homepage